Explore Vaccination Progress by U.S. State
With dozens of COVID-19 vaccines now in clinical trials, it is important to understand the accelerated timelines for development, the different types of vaccines available, and the facts related to vaccine safety and efficacy. Additionally, as vaccines are approved, we will track data on vaccination efforts.
An interactive tool from our vaccine experts that explores how a vaccine is developed and the differences between a typical timeline and an accelerated timeline.
VIEW-hub is a publicly available interactive tool that displays up-to-date information on vaccine characteristics, and vaccine introduction and use globally. Vaccines include COVID-19 as well as many childhood vaccines in routine immunization programs.
Recent news that nine vaccinated baseball players for the New York Yankees tested positive for SARS-CoV-2, the virus that causes COVID-19, has thrust the concept of “breakthrough infections” to the forefront of public discourse about U.S. vaccination efforts.
While cases continue to decline in the United States amid its successful mass vaccination efforts, many nations are struggling with new surges.
The United States government and partners in the pharmaceutical industry developed, manufactured, and evaluated safe and effective COVID-19 vaccines in record time. One last monumental task awaits: Getting vaccines to the hardest-to-reach individuals and those who are hesitant to be vaccinated, allowing vaccine supplies to exceed demand.
This series of brief reports will shed light on COVID-19 vaccine development, allocation and deployment in the United States and globally. Topics will include ensuring the safety and efficacy of Covid-19 vaccines, principles for vaccine allocation, strategies for deployment and delivery of Covid-19 vaccines, vaccine confidence and demand, and the economics of Covid-19 vaccines.
COVID-19 VACCINE MATTERS: A blog series discussing the evolving science and policy of COVID-19 vaccines, led by internationally renowned experts in vaccine development, Dr. Larry Corey of the Univeristy of Washington, and Dr. Chris Beyrer of Johns Hopkins University.
Johns Hopkins University and the University of Washington hosted a high-level symposium, “The Scientific Integrity of COVID-19 Vaccine Efficacy Trials: From Clinical Trials to Public Allocation,” that explored complex issues, brought together leading voices in the field, and put forward a concise plan for protecting the scientific integrity of these ongoing efforts.
One-third of unvaccinated U.S. adults say they will only get in line for the COVID-19 jab once it's fully approved, but medical experts say it can also be risky to wait.
Researchers and health officials suspect that the immunity against COVID-19 these vaccines elicit in the body might wane over long periods of time and might not protect as well against coronavirus variants that could emerge and evolve.
A New York Yankees player and several team staffers tested positive for the coronavirus although they were vaccinated, the baseball club said this week, underscoring that it’s possible to get an infection even after the shots.
Johns Hopkins Center for Health Security Senior Scholar Jennifer Nuzzo discusses domestic and international travel, vaccinations for kids, and the need for more vaccine access around the world.
Johns Hopkins Center for Health Security Senior Scholar Jennifer Nuzzo discusses the debate over patent protection for COVID-19 vaccines.
The Food and Drug Administration is set to authorize the Pfizer-BioNTech vaccine for use in 12-to-15-year-olds by early next week.
The Food and Drug Administration is preparing to authorize use of the Pfizer-BioNTech coronavirus vaccine in adolescents 12 to 15 years old by early next week.
Jennifer Nuzzo discusses herd immunity and vaccine hesitancy in the United States and how those trends may impact the country's return to "normalcy."
Health experts said that people who contract COVID-19 in the middle of their vaccine series should still get the second dose.
Virtually all adults in the U.S. who want to get vaccinated will have been able to get a shot by July, yet relatively few children, especially younger children, will have been vaccinated by then.
In America, adults are racing headlong into a post-vaccination summer while kids are being left in vaccine limbo.